At Johnson & Johnson, we are committed to improving health and well-being. We stand for innovation, safety, and caring. Our aim is to make a positive impact on lives worldwide.
Belgium hosts key research, development, and manufacturing facilities, particularly in Beerse and Geel. These sites are essential for producing pharmaceutical products and supporting innovation through research centers. Johnson & Johnson Belgium started out as Janssen Pharmaceutica and became a part of J&J in 1961.
Our immunology division is dedicated to developing innovative therapies for immune-mediated diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It is this expertise that aligns perfectly with being a partner of BIRD.
Since a few years we have our Belgian podcast ‘The Gut Feeling’ where we discuss what living with Inflammatory Bowel Disease (IBD) can entail.